• 한국산학기술학회논문지
• /
• 제8권5호
• /
• pp.1266-1272
• /
• 2007

본 연구는 육성돈에 있어 복합생균제 급여가 생산성, 영양소 소화율, 혈액성상 및 분뇨내 악취물질 발생량에 미치는 효과를 규명하고자 실시하였다. 육성돈 48두를 공시하였으며, 시험 개시시 체중은 20.12kg이었다. 시험설계는 1) CON (basal diet), 2) Pro1 (basal diet + 0.1% complex probiotics) and 3) Pro2 (basal diet + 0.2% complex probiotics)으로 총 3처리를 하여 처리당 8반복, 반복당 2두씩 완전임의 배치하였다. 사양시험은 6주간 실시하였다 전체 시험기간동안 일당증체량은 생균제 첨가 수준이 증가함에 따라 유의적으로 증가하였다(P<0.05). 그러나 생균제 급여는 일당사료섭취량 및 사료효율에 영향을 미치지 못하였다. 복합 생균제 급여는 건물 소화율을 증가시켰다(linear effect, P<.0.05). 또한 질소 소화율을 개선시켰으며, Pro 1 처리구가 가장 높게 나타났다(linear and quadratic effect, P<0.05). 생균제 급여는 혈액내 WBC, RBC, lymphocyte 및 BUN함량에 영향을 미치지 못하였다. 생균제 첨가 수준의 증가함에 따라 분뇨내 $NH_3-N$ 발생량은 감소하였으며(linear and quadratic effect, P<0.05), $H_2S$ 발생량은 감소하였다(linear and quadratic effect, P<0.05). 결론적으로 사료내 복합생균제의 첨가 급여는 생산성을 증가시켰으며, 분뇨내 악취물질 발생량을 감소 시켰다.

• Bulletin of the Korean Chemical Society
• /
• 제24권8호
• /
• pp.1203-1206
• /
• 2003

Analysis of health-related microbes called probiotics was performed by capillary electrophoresis. A rapid and easy characterization for two important probiotics, Saccharomyces cerevisiae and Enterococcus feacalis, was obtained in the running buffer containing poly(ethylene oxide). Quantitation of probiotic (Saccharomyces cerevisiae) shows a good linearity between the peak area versus the concentration of microbe. From the comparison of electropherograms of antidiarrhea, it was found that capillary electrophoresis could be employed for the quality control and quality assurance for the production of a medicine containing the probiotics.

• 한국가금학회지
• /
• 제30권3호
• /
• pp.203-209
• /
• 2003

본 실험은 육계에 서로 다른 혼합미생물을 급여하여 효과를 구명하고자 실행하였다. 1일령 로스 수컷 400수에 무첨가구인 대조구와 생균제 A와 B를 각각 0.1과 0.2%수준으로 5개처리구 5반복 반복당 16수씩 평사로 5주간 급여하였다. 증체량, 사료섭취량, 사료요구율을 주간별로 측정하였으며, 실험 종료시에 회장과 맹장의 전체 유산균, 효모균, 살모넬라, 대장균 수를 조사하였다. 혈장의 단백질, 콜레스테롤, ND 백신항체가를 측정하였고, 분에서 발생되는 $CO_2$, NH$_3$. COD를 측정하였다. 증체량은 사육 초기 3주간에 생균제 급여구에서 대조구보다 높은 경향이었으며, 후기 2주간에는 현저하게 높았다(P<0.05). 사료섭취량은 처리구간에 통계적인 차이가 없었으며, 사료요구율은 생균제 B 처리구에서 다른 처리구보다 유의적으로 개선되었다. 전체 살모넬라 수는 회장에서 일관성이 없었지만 대장균수는 생균제 급여구에서 대조구에 비하여 낮게 나타났다. 분에서 NH$_3$와 $CO_2$ 발생도 생균제 급여구에서 대조구에 비하여 낮았지만 통계적인 차이는 없었으며 계분의 COD는 다른 유해가스의 발생과 동일한 경향을 나타냈다. 혈중 전체 콜레스테롤은 생균제 종류에 관계없이 낮은 경향을 나타냈다. ND백신 항체가는 생균제 급여구에서 높아지는 경향을 나타냈다.

• Asian-Australasian Journal of Animal Sciences
• /
• 제31권10호
• /
• pp.1660-1669
• /
• 2018

Objective: This study was conducted to evaluate the effect of probiotics (Bacillus subtilis and Enterococcus faecium) and xylo-oligosaccharide (XOS) supplementation on growth performance, nutrient digestibility, serum profiles, intestinal health, fecal microbiota and noxious gas emission in weanling pigs. Methods: A total of 240 weanling pigs ([Yorkshire${\times}$Landrace]${\times}$Duroc) with an average body weight (BW) of $6.3{\pm}0.15kg$ were used in this 28-day trial. Pigs were randomly allocated in 1 of the following 4 dietary treatments in a $2{\times}2$ factorial arrangement with 2 levels of probiotics (0 and 500 mg/kg probiotics) and XOS (0 and 200 mg/kg XOS) based on the BW and sex. Results: Administration of probiotics or XOS improved average daily gain (p<0.05) during 0 to 14 d and the overall period, while pigs that were treated with XOS had a greater average daily gain and feed efficiency (p<0.05) compared with unsupplemented treatments throughout 15 to 28 d and the whole experiment. Either probiotics or XOS treatments increased the apparent total tract digestibility of nutrients (p<0.05) during 0 to 14 d. No effects on serum profiles were observed among treatments. The XOS increased villus height: crypt depth ratio in jejunum (p<0.05). The supplementation of probiotics (500 mg/kg) or XOS (200 mg/kg) alone improved the apparent total tract digestibility of dry matter, nitrogen and gross energy on d 14, the activity of trypsin and decreased fecal NH3 concentration (p<0.05). Administration of XOS decreased fecal Escherichia coli counts (p<0.05), while increased lactobacilli (p<0.05) on d 14. There was no interaction between dietary supplementation of probiotics and XOS. Conclusion: Inclusion of XOS at 200 mg/kg or probiotics (Bacillus subtilis and Enterococcus faecium) at 500 mg/kg in diets containing no antibiotics significantly improved the growth performance of weanling pigs. Once XOS is supplemented, further providing of probiotics is not needed since it exerts little additional effects.

• Asian-Australasian Journal of Animal Sciences
• /
• 제14권10호
• /
• pp.1425-1428
• /
• 2001

This study was conducted to investigate the effects of supplementation of a probiotics complex on growth performance, nutrient digestibility, diarrhea score and microbial population in pigs weaned at 21 days of age. Treatments were 1) control A (0.2% antibiotics, Avilamycin), 2) control B (0.1 % $Ractocom^{(R)}$), 3) 0.1%, 4) 0.2% and 5) 0.3% probiotics complex; 80 pigs were used and each treatment had 4 replicates with 4 pigs per replicate (16 pigs per treatment). During phase I period (d 0 to 14), although there was no significant difference, pigs fed control B diet showed higher ADG (average daily gain) and better F/G (feed/gain) than any other treatments. During late experimental period (d 15 to 28), pigs fed diet supplemented with 0.2% probiotics complex showed slightly higher ADG. Overall (d 0 to 28) the diet that contained 0.2% probiotics complex gave slightly higher ADG and ADFI (average daily feed intake) than the other diets. In a metabolic trial using 20 piglets, nutrient digestibility showed the best results in pigs fed 0.2% probiotics complex diet, but not significantly different from other groups. Diarrhea score and microbial population status in intestine, colon and feces were not affected by dietary treatments. In conclusion, this study suggested that a newly developed probiotics complex can replace antibiotics in weaned pigs.

• Clinical and Experimental Pediatrics
• /
• 제56권9호
• /
• pp.369-376
• /
• 2013

A complex interplay between genetic and environmental factors partially contributes to the development of allergic diseases by affecting development during prenatal and early life. To explain the dramatic increase in the prevalence of allergic diseases, the hygiene hypothesis proposed that early exposure to infection prevented allergic diseases. The hygiene hypothesis has changed to the microbial hypothesis, in which exposure to microbes is closely linked to the development of the early immune system and allergic diseases. The intestinal flora may contribute to allergic disease through its substantial effect on mucosal immunity. Based on findings that exposure to microbial flora early in life can change the Th1/Th2 balance, thus favoring a Th1 cell response, probiotics may be beneficial in preventing allergic diseases. However, evidence from clinical and basic research to prove the efficacy of probiotics in preventing allergy is lacking. To date, studies have yielded inconsistent findings on the usefulness of probiotics in allergic diseases. It is difficult to demonstrate an exact effect of probiotics on asthma, allergic rhinitis, and food allergy because of study limitations, such as different first supplementation period, duration, different strains, short follow-up period, and host factors. However, many studies have demonstrated a significant clinical improvement in atopic dermatitis with the use of probiotics. An accurate understanding of the development of human immunity, intestinal barrier function, intestinal microbiota, and systemic immunity is required to comprehend the effects of probiotics on allergic diseases.

• 한국축산식품학회지
• /
• 제32권4호
• /
• pp.434-440
• /
• 2012

It has been suggested that probiotics could be useful for the prevention of symptomatic relapse in patients with inflammatory bowel disease (IBD). Interleukin (IL)-8 has been well recognized as one of the pro-inflammatory cytokines that could trigger inflammation and epithelial barrier dysfunction. In this study, the anti-inflammatory effects of probiotics were investigated using a human epithelial cell line (HT-29). Probiotics from infant feces and kimchi were tested for their cytotoxicity and effects on adhesion to epithelial cells. The present results show that seven strains could form 70 % adhesion on HT-29. The probiotics used in this study did not affect HT-29 cell viability. To screen anti-inflammatory lactic acid bacteria, HT-29 cells were pretreated with live and heat-killed probiotics, and lipopolysaccharide (LPS) ($1{\mu}g/mL$) was then added to stimulate the cells. The cell culture supernatant was then used to measure IL-8 secretion by ELISA, and the cell pellet was used to determine IL-8 and toll-like receptor (TLR-4) mRNA expression levels by RT-PCR. Some probiotics (KJP421, KDK411, SRK414, E4191, KY21, and KY210) exhibited anti-inflammatory effects through the repression of IL-8 secretion from HT-29 cells. In particular, Lactobacillus salivarius E4191, originating from Egyptian infant feces, not only decreased IL-8 mRNA expression, but also decreased TLR-4 expression. These results indicate that Lactobacillus salivarius E4191 may have a protective effect in intestinal epithelial cells.

• 한국축산식품학회지
• /
• 제43권4호
• /
• pp.612-624
• /
• 2023

The gut-brain axis encompasses a bidirectional communication pathway between the gastrointestinal microbiota and the central nervous system. There is some evidence to suggest that probiotics may have a positive effect on cognitive function, but more research is needed before any definitive conclusions can be drawn. Inflammation-induced by lipopolysaccharide (LPS) may affect cognitive function. To confirm the effect of probiotics on oxidative stress induced by LPS, the relative expression of antioxidant factors was confirmed, and it was revealed that the administration of probiotics had a positive effect on the expression of antioxidant-related factors. After oral administration of probiotics to mice, an intentional inflammatory response was induced through LPS i.p., and the effect on cognition was confirmed by the Morris water maze test, nitric oxide (NO) assay, and interleukin (IL)-1β enzyme-linked immunosorbent assay performed. Experimental results, levels of NO and IL-1β in the blood of LPS i.p. mice were significantly decreased, and cognitive evaluation using the Morris water maze test showed significant values in the latency and target quadrant percentages in the group that received probiotics. This proves that intake of these probiotics improves cognitive impairment and memory loss through anti-inflammatory and antioxidant mechanisms.

• 미생물학회지
• /
• 제49권1호
• /
• pp.24-29
• /
• 2013

본 연구는 prebiotics와 probiotics가 in vitro 배양조건에서 돼지 장내 미생물 및 발효산물에 미치는 영향에 대하여 검토 하였다. prebiotics로써 이소말토-올리고당(IMO), 부분분해 치커리이눌린(CI), 라피노스(RA), 사이클로덱스트린(CD)을 사용하였으며 probiotics로는 Lactobacillus reuteri를 사용하였다. In vitro 발효시험은 육성돈 사료를 소화효소로 가수분해 시킨 사료와 5%의 돈분 그리고 prebiotics와 probiotics를 첨가 또는 무첨가하여 24시간 동안 배양시켰다. 배양 후 발효액 내의 미생물, 가스, pH, 암모니아, 황화수소, 단쇄지방산을 분석하였다. 엔테로박테리아는 prebiotics와 probiotics 첨가구가 대조구와 비교하여 유의적으로 감소하였으며, 락토바실러스 수는 유의적으로 증가하였다. 발효액의 pH는 대조구에 비하여 첨가구에서 낮았으며 prebiotics보다 prebiotics+probiotics 첨가구에서 더욱 낮았다. 암모니아, 황화수소 및 스카톨의 농도는 prebiotics+probiotics 구보다 prebiotics 첨가시 유의적으로 감소하였다. 단쇄지방산은 prebiotics 보다 prebiotics+probiotics 구에서 유의적으로 많이 생성되었다. 본 시험의 결과 prebiotics 첨가는 암모니아, 황화수소 및 스카톨의 농도를 감소시키는데 효과가 있었으며, prebiotics+probiotics는 유산균과 단쇄지방산의 농도를 증가시키는 효과가 있었다. In vitro에서 얻어진 실험 결과가 실제로 돼지에 급여 시 같은 결과가 얻어질런지에 대한 추가적인 연구가 필요하다.

• Clinical and Experimental Pediatrics
• /
• 제48권7호
• /
• pp.691-695
• /
• 2005

There is scientific evidence that administration of probiotics is effective in the treatment of acute infectious diarrhea in children and the prevention of antibiotic associated diarrhea and nosocomial/community acquired diarrhea. Probiotics prevent relapse of recurrent pouchitis and decrease the initial onset of pouchitis in ulcerative colitis. Probiotic organisms suppress growth of pathogens as well as their epithelial attachment and/or invasion either directly by secreting antimicrobial substances or by stimulating host expression of protective molecules. Additionally, probiotics enhance mucosal barrier function and can stimulate host production of immunosuppressive molecules that downregulate inflammatory responses or allergic immune response. Mechanisms of action explain therapeutic effects and randomized controlled trials are warranted before recommendations for therapeutic or preventive use can be given.